Related Experiment Video
Updated: Mar 25, 2026
07:40
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
4.3K
Obesity in Older Adults.
1Department of Family Medicine, National Capital Consortium Family Medicine Residency, Fort Belvoir Community Hospital, 9300 Dewitt Loop, Fort Belvoir, VA 22060, USA.
Primary Care
|February 21, 2016
Summary
Obesity in older adults negatively impacts quality of life and function. Weight loss plans for seniors should incorporate aerobic, balance, and resistance exercises to preserve physical function.
Area of Science:
- Gerontology
- Obesity Medicine
- Preventive Medicine
Background:
- Rising prevalence of obesity in older adults.
- Underestimation of obesity's health consequences in the elderly by clinicians.
- Concerns regarding potential negative impacts of weight loss on older adults' health.
Purpose of the Study:
- To highlight the adverse effects of obesity on quality of life and function in older adults.
- To emphasize the importance of appropriate weight management strategies for elderly individuals.
Main Methods:
- Review of existing literature on obesity in older adults.
- Analysis of the impact of excess weight on functional capacity and quality of life in the elderly.
Main Results:
- Obesity in older adults adversely impacts quality of life and physical function.
- While not carrying the same mortality risk as in younger populations, obesity poses significant challenges for elderly individuals.
Conclusions:
- Weight loss interventions for older adults are crucial for improving functional status.
- Recommended weight loss plans should integrate aerobic, balance, and resistance exercises to optimize physical function in the elderly.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:21Drug Dosing: Obese Patients
335
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
368
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
368
01:15Drug Dosing: Geriatric Patients
345
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
330
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
279
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
279